MedTrace Logo

Correlation of CO2 Measured by Blood Gas vs Transcutaneous Monitor

NCT03268395 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2017-08-31

No results posted yet for this study

Summary

The purpose of this clinical investigation is to compare transcutaneous CO2 (TCCO2) levels measured non-invasively using the SenTec Transcutaneous CO2 Monitor to PaCO2 levels measured on arterial blood gas (ABG) samples in neonatal patients being treated for respiratory distress in the Neonatal Intensive Care Unit (NICU) at Memorial University Medical Center.

Conditions

  • Respiratory Complication

Interventions

DIAGNOSTIC_TEST

Arterial Blood Gas and Transcutaneous CO2 Monitor

Each patient will receive both an arterial blood gas and a transcutaneous CO2 monitor test.

Sponsors & Collaborators

  • Memorial Health University Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-29
Primary Completion
2018-08-29
Completion
2018-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03268395 on ClinicalTrials.gov